StonvexLoading…
StonvexStonvexStonvexCore line items from NRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $30.35B | $27.75B | $28.26B | $31.49B |
Operating Income | $1.84B | $2.42B | $384.00M | $2.02B |
Net Income | $864.00M | $1.13B | $-202.00M | $1.22B |
EPS (Diluted) | $4.01 | $4.99 | $-1.12 | $5.17 |
Total Assets | $29.14B | $24.02B | $26.04B | $29.15B |
Total Liabilities | $27.46B | $21.54B | $23.13B | $25.32B |
Cash & Equivalents | $4.71B | $966.00M | $541.00M | $430.00M |
Free Cash Flow OCF − CapEx | $766.00M | $1.83B | $-819.00M | $-7.00M |
Shares Outstanding | 190.38M | 198.60M | 208.13M | 229.56M |